Is Moderna “The Tesla Of Biotech”?
Shares of Moderna are popping in anticipation of it joining the S&P 500 on July 21 – and the analyst cited in today’s article believes… Read More »Is Moderna “The Tesla Of Biotech”?
Moderna
Who’s The MVP In mRNA?
Messenger RNA (mRNA) has come to the forefront thanks to its role in the Pfizer-BioNTech and Moderna COVID-19 vaccines – and the potential for the… Read More »Who’s The MVP In mRNA?
3 Biotech Stocks To Watch As 2021 Gets Underway
When it comes to the biotech stocks that experienced strong growth in 2020, the author of today’s article notes that the “more obvious cases such… Read More »3 Biotech Stocks To Watch As 2021 Gets Underway
The Co-Managers Of An Outperforming Fund Share 3 Biotech Firms Poised To Solve Future Disease Outbreaks
The Shelton Green Alpha Fund is up more than 100% year-to-date and is among the best-performing funds of 2020 – and a big reason for… Read More »The Co-Managers Of An Outperforming Fund Share 3 Biotech Firms Poised To Solve Future Disease Outbreaks
Which Frontrunner’s COVID-19 Vaccine Candidate May Hold The Most Promise – And Why?
Of four frontrunners in the race for a vaccine for COVID-19 – Moderna, Pfizer and BioNTech, Inovio Pharmaceuticals, and AstraZeneca – is there any indication… Read More »Which Frontrunner’s COVID-19 Vaccine Candidate May Hold The Most Promise – And Why?
Why This “Picks And Shovels” Stock Could Be A Better COVID-19 Play Than Moderna
Moderna could strike gold when it comes to its COVID-19 vaccine candidate – or it could flop. Either way, the under-the-radar “picks-and-shovels” stock highlighted in… Read More »Why This “Picks And Shovels” Stock Could Be A Better COVID-19 Play Than Moderna